CLINICAL_TRIALS
trial_result
· 2012-06-04
Clinical Trial Update: Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee [Phase 3]
Summary
Phase 3 trial of 1.2% sodium hyaluronate for painful chronic osteoarthritis of the knee completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferring Pharmaceuticals | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED | Results posted: 2012-06-04